Farnesol, a Sesquiterpene Alcohol in Herbal Plants, Exerts Anti-Inflammatory and Antiallergic Effects on Ovalbumin-Sensitized and -Challenged Asthmatic Mice

Table 2

Effects of farnesol supplementation with different doses for 5 weeks on initial and final body weights and food and energy intake, as well as feed and energy efficiencies of OVA/AL-sensitized and -challenged BALB/c asthmatic mice.

Groups		Initial body weight	Final body weight	Body weight gain	Feed intake	Energy intake	Feed efficiency	Energy efficiency
		(g)	(g)	(g/d)	(g/d)	(kcal/day)	(g gain/100 g feed)	(g gain/100 kcal feed)
DC	13	19.1 ± 1.6	21.7 ± 0.8	0.07 ± 0.02	4.28 ± 0.62	16.5 ± 2.4	1.74 ± 0.57	0.45 ± 0.06
FL	14	19.1 ± 1.4	22.3 ± 1.5	0.09 ± 0.02	4.37 ± 0.46	16.8 ± 1.8	2.06 ± 0.49	0.54 ± 0.13
FM	12	19.2 ± 1.5	22.0 ± 1.4	0.08 ± 0.02	4.81 ± 0.27	18.5 ± 1.0	1.67 ± 0.27	0.43 ± 0.07
FH	14	19.2 ± 1.5	22.4 ± 1.8	0.09 ± 0.02	4.70 ± 0.34	18.1 ± 2.0	1.97 ± 0.38	0.51 ± 0.10
PC	14	19.2 ± 1.6	21.8 ± 0.9	0.07 ± 0.02	4.55 ± 0.31	17.5 ± 1.2	1.65 ± 0.60	0.43 ± 0.16
NSC	15	19.1 ± 1.4	21.5 ± 1.0	0.07 ± 0.02	3.82 ± 0.40	14.7 ± 1.5	1.81 ± 0.78	0.47 ± 0.20

Values are means ± SD. There are no significant differences among groups within same column assayed by one-way ANOVA, followed by Duncan’s new multiple range test. NSC, nonsensitized control; DC, dietary control; PC, positive control; FL, low dose farnesol (0.003% in AIN-76 feed); FM, medium dose farnesol (0.017% in AIN-76 feed); FH, high dose farnesol (0.067% in AIN-76 feed).